NMW: Prescription Antidepressants Recalled Over Cancer-Causing Nitrosamines
NMW reports a significant recall of over 7,100 bottles of d duloxetine, a medication frequently used to treat depression. This recall has been prompted by the identification of nitrosamines, substances recognized for their potential cancer-causing properties. The FDA has emphasized the importance of monitoring these health risks linked to commonly prescribed medications.
Details of the Recall
The pharmaceutical company conducted this recall in compliance with safety standards. Here are the critical points:
- Product Name: Duloxetine delayed-release capsules
- Quantity Recalled: Over 7,100 bottles
- Reason for Recall: Presence of elevated nitrosamines
Health Implications
It is crucial for patients currently using duloxetine to consult their healthcare provider regarding this recall. Understanding the implications of potential nitrosamine exposure can significantly affect patient health outcomes.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.